Loading the session
Loading the session
Loading instrument
$55.62
+6.55%Market closedDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:25 IST · A quote does not mean the product is available to trade on your account.
In brief
Questions investors ask
Quotes run fifteen minutes behind.
1 month: +14.7% (SPY −1.6%, XLV +13.5%). 3 months: +50.6% (SPY −0.4%, XLV +15.5%). 1 year: +255.3% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: PLSE, SPY and XLV · as of 4 Nov 2026
Closed at $57.06 on 4 Nov 2026: 3.1% below the 52-week high of $58.90 (9 Sep 2026) and 354.3% above the low of $12.56 (20 Nov 2025).
Daily price bars, split-adjusted · as of 4 Nov 2026
3.0M shares were sold short at the 15 Oct 2026 settlement, 4.2% of the 70.8M shares outstanding; covering them would take 7.2 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
The 4 Nov 2026 close of $57.06 was 11.1% above its 50-day average ($51.35) and 78.6% above its 200-day average ($31.95). It has closed above the 200-day for 188 sessions, since 6 Feb 2026. The 50-day average crossed above the 200-day on 20 Feb 2026, 178 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Price return, split-adjusted
At the 4 Nov 2026 close
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
February 6, 2026
+51.57%April 13, 2023
+40.12%March 31, 2023
+35.48%